Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

    Oct 16, 2023, 08:47 AM by
    Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency
    Full story
  • Navigating the Data-Rich Landscape of Healthcare: The Utility of Data Exploration and Visualization

    Oct 13, 2023, 01:00 AM by User Not Found
    Bio-IT World| In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents 5 takeaways relevant to these strategies.
    Full story
  • Low-Bass Music Controls Insulin Release From Designer Cells

    Oct 11, 2023, 01:00 AM by User Not Found
    Bio-IT World| Scientists in Switzerland have figured out how to remotely control genes in a way that could one day enable diabetics to produce and administer insulin directly in their body rather than relying on injections, inhalers, and pumps. Low-bass heavy popular music and movie soundtracks are being used to trigger insulin release from designer cells in implantable capsules when intentionally directed at the implant site.
    Full story
  • Proteomics Enables Vastly Improved Cardiovascular Disease Prediction

    Oct 10, 2023, 01:00 AM by User Not Found
    Bio-IT World| The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment.
    Full story
  • Children’s Mercy Brings Long Read Sequencing to Clinical Care

    Oct 6, 2023, 07:30 AM by User Not Found
    Bio-IT World Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
    Full story
  • Sharp acquires Berkshire Sterile Manufacturing

    Oct 6, 2023, 05:39 AM by
    Full story
  • X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

    Oct 6, 2023, 05:39 AM by
    Full story
  • Firstsource Positioned as a ‘Leader’ and a ‘Star Performer’ in Everest Group Healthcare Payer Operations PEAK Matrix® Assessment 2023

    Oct 6, 2023, 05:39 AM by
    About Firstsource Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL, BSE: 532809, Reuters: FISO.BO, Bloomberg: FSOL:IN), is a leading provider of transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, and other industries. The Company’s ‘Digital First, Digital Now’ approach helps organizations reinvent operations and reimagine business models, enabling them to deliver moments that matter and build competitive advantage. With an established presence in the US, the UK, Mexico, India, and the Philippines, Firstsource acts as a trusted growth partner for over 150 leading global brands, including several Fortune 500 and FTSE 100 companies. (www.firstsource.com)
    Full story
  • InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023

    Oct 5, 2023, 08:24 AM by
    InsightRX to Present Multiple Studies Demonstrating Advances in Precision Medicine at IDWeek 2023 - Recent research highlights the potential for model-informed precision dosing to improve patient safety, enhance clinical practice and reduce the cost of care
    Full story
  • Phastar Net-Zero Target Approved by the Science Based Targets Initiative

    Oct 5, 2023, 08:24 AM by
    Phastar Net-Zero Target Approved by the Science Based Targets Initiative Phastar commits to achieving Net-Zero Standard by 2035
    Full story
  • BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa

    Oct 4, 2023, 07:26 AM by
    Expert staff will be on hand at the conference to discuss how BioIVT can support CGT research from discovery and development to commercialization.
    Full story
  • Almaden Genomics Adds Pre-Built Workflows to g.nome, Facilitating and Speeding Single-Cell RNA-seq Analysis

    Oct 4, 2023, 07:26 AM by
    Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms on a much more granular level. By unlocking single-cell sequencing data through efficient and powerful analysis, g.nome can now help researchers better understand cellular heterogeneity and gene expression.
    Full story
  • AVIA’s National Generative AI Collaborative Grows to Nearly Thirty Major Health Systems

    Oct 4, 2023, 07:26 AM by
    Full story
  • Synthace’s ‘Design of Experiments’ Approach Enables Multi-Factorial Wet Lab Experiments

    Oct 4, 2023, 01:00 AM by User Not Found
    Bio-IT World| INNOVATIVE PRACTICES AWARDS—Cultured meat may not be the standard use case for a Bio-IT World Innovative Practices Award, but the entry from Higher Steaks and Synthace caught the judges’ attention less for its application as for the innovation in experimental design.
    Full story
  • BioIVT to Host a Webinar on Optimizing Liquid Biopsy Research

    Oct 3, 2023, 08:39 AM by
    This webinar will discuss the importance of using standardized collection protocols and a diverse donor base to validate biomarkers and ensure their clinical utility.
    Full story
  • Scitara and IDT present a composable IT architecture platform at Lab of The Future Europe 2023

    Oct 3, 2023, 08:39 AM by
    Full story
  • Bio-IT World Issues 2024 Innovative Practices Awards Call for Entries

    Oct 3, 2023, 01:00 AM by User Not Found
    Bio-IT World| Bio-IT World is accepting entries for the 2024 Innovative Practices Awards, a competition designed to recognize the most exciting partnerships and projects pushing the life sciences industry forward.
    Full story
  • Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences

    Oct 2, 2023, 08:47 AM by
    Executive Team Charts Path to Future Approval as the World Awaits a Historic Breakthrough in Precision Medicine
    Full story
  • Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

    Oct 2, 2023, 08:47 AM by
    Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.
    Full story
  • New hot start isothermal mixes boost sensitivity, specificity, and speed of DNA target detection

    Sep 29, 2023, 08:38 AM by
    PCR Biosystems, a leading PCR reagent developer, has launched a new range of Bst polymerase reagents that offer greater sensitivity, speed, and specificity in all isothermal amplification applications.
    Full story
  • «
  • 71 (current)
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy